Literature DB >> 28839611

A debate on the roles of antireflux surgery and long term acid suppression in the management of gastro-oesophageal reflux disease.

Stephen E Attwood1, Jean Paul Galmiche2.   

Abstract

Entities:  

Year:  2011        PMID： 28839611      PMCID： PMC5517238          DOI： 10.1136/fg.2010.003962

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  40 in total

1.  Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study.

Authors:  Michael Camilleri; Dominique Dubois; Bernard Coulie; Michael Jones; Peter J Kahrilas; Anne M Rentz; Amnon Sonnenberg; Vincenzo Stanghellini; Walter F Stewart; Jan Tack; Nicholas J Talley; William Whitehead; Dennis A Revicki
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

2.  Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Authors:  D A Johnson; S B Benjamin; N B Vakil; J L Goldstein; M Lamet; J Whipple; D Damico; B Hamelin
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

Review 3.  Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

Authors:  C Donnellan; N Sharma; C Preston; P Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

4.  The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study.

Authors:  O Diav-Citrin; J Arnon; S Shechtman; C Schaefer; M R van Tonningen; M Clementi; M De Santis; E Robert-Gnansia; E Valti; H Malm; A Ornoy
Journal:  Aliment Pharmacol Ther       Date:  2005-02-01       Impact factor: 8.171

5.  Day-case laparoscopic Nissen fundoplication.

Authors:  M E Bailey; W V Garrett; A Nisar; N H Boyle; G H Slater
Journal:  Br J Surg       Date:  2003-05       Impact factor: 6.939

6.  Prevention of erosive oesophagitis relapse with pantoprazole.

Authors:  J E Richter; P Fraga; M Mack; S M Sabesin; W Bochenek
Journal:  Aliment Pharmacol Ther       Date:  2004-09-01       Impact factor: 8.171

7.  Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn.

Authors:  E J Patterson; D G Davis; Y Khajanchee; L L Swanström
Journal:  Surg Endosc       Date:  2003-07-21       Impact factor: 4.584

8.  Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative.

Authors:  M Kulig; A Leodolter; M Vieth; E Schulte; D Jaspersen; J Labenz; T Lind; W Meyer-Sabellek; P Malfertheiner; M Stolte; S N Willich
Journal:  Aliment Pharmacol Ther       Date:  2003-10-15       Impact factor: 8.171

9.  Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.

Authors:  R Duane Davis; Christine L Lau; Steve Eubanks; Robert H Messier; Denis Hadjiliadis; Mark P Steele; Scott M Palmer
Journal:  J Thorac Cardiovasc Surg       Date:  2003-03       Impact factor: 5.209

10.  Mortality study of 18 000 patients treated with omeprazole.

Authors:  D N Bateman; D Colin-Jones; S Hartz; M Langman; R F Logan; J Mant; M Murphy; K R Paterson; R Rowsell; S Thomas; M Vessey
Journal:  Gut       Date:  2003-07       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.